Wishing you all the joys of the season! 
South & Central America Brain Implants Market Forecast to 2030
South & Central America Brain Implants Market Forecast to 2030 – Regional Analysis – by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Strategic Initiatives by Companies Fuels South & Central America Brain Implants Market
Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. For example, in December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company’s portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360.
Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the South & Central America brain implants market.
South & Central America Brain Implants Market Overview
The South & Central America brain implants market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America will likely account for over 9.0% of the brain implant market during 2022-2030. The prevalence of neurological disorders, such as Parkinson’s disease and Alzheimer’s disease, has been linked to the aging population in Brazil. According to the data from the Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and above, representing 13% of the country’s population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazilian Institute of Country and Statistics, the country’s population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. As per the study, “Trends in mortality from Alzheimer’s disease in Brazil, 2000-2019,” published in 2023, in Brazil, Alzheimer’s disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country in recent years. There was a 49% increase in deaths due to Alzheimer’s disease between 2009 and 2019 in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to Alzheimer’s disease in the same period in Brazil, 64% of which were female. Furthermore, 73% of the deaths were related to people aged 80 and above, and 27% were in the 60-79 age group. Thus, the abovementioned factors are expected to increase the demand for brain implants for the treatment of these neurological diseases in the country in the coming years.
South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Brain Implants Market Segmentation
The South & Central America brain implants market is segmented into treatment, application, end user, and country.
Based on treatment, the South & Central America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held the largest share in 2022. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.
In terms of application, the South & Central America brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.
Based on end user, the South & Central America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.
Based on country, the South & Central America brain implants market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America brain implants market in 2022.
Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Renishaw Plc are some of the leading companies operating in the South & Central America brain implants market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America brain implants market was valued at US$ 366.05 million in 2022 and is expected to reach US$ 730.98 million by 2030, registering a CAGR of 9.0% from 2022 to 2030. Technological advancements such as miniaturization, artificial intelligence, and modern brain-machine interfaces and rising number of spinal cord injuries are among the critical factors attributed to the South & Central America brain implants market expansion.
Advancements in technology have led to the development of smaller, more compact brain implants, making them more suitable for noninvasive or minimally invasive surgical procedures. Improved electrode designs, advanced programming algorithms, 3D printing, brain-computer interfaces (BCI), motor neuron prostheses, self-charging implants, memory chips, and miniaturization are a few of the modern trends in the South & Central America brain implants market, which are likely to improve the effectiveness of treatments. These innovations provide patients with greater customization, adaptability, and other long-term benefits. In addition to the development of smaller and more flexible implants, advancements in wireless communication and power delivery systems can enhance the functionality and usability of brain implants. By reducing the invasiveness and improving the user experience, these advancements can expand the potential applications of brain implants and attract a broader patient population. Furthermore, these advancements benefit patients who require long-term implants, as smaller devices can lower the risk of complications and allow for easier placement and removal.
The integration of artificial intelligence (AI) and machine learning algorithms can further optimize the performance of brain implants by enabling personalized therapies and real-time adaptive stimulation. AI-powered neural implants have the potential to improve patients’ quality of life, particularly those suffering from Alzheimer’s disease. Recent research indicates that AI-powered brain-machine interfaces can effectively identify and track the progression of Alzheimer’s, leading to earlier diagnosis and intervention. Innovations in BCI technology have provided new ways for communication and control for individuals with severe disabilities. BCIs can enable individuals with locked-in syndrome or spinal cord injuries to interact with their surroundings using their thoughts. These implants can decode neural signals and translate them into commands for external devices, such as prosthetic limbs or computer interfaces.
Companies such as Medtronic, Neuropace, and St. Jude Medical are developing systems to actively monitor brain activity. Some monitoring systems are used in conjunction with other assistive devices, such as robotic aids, to help patients suffering from neurological disorders to regain lost motor function.
On the contrary, high cost associated with brain implant devices and procedures hampers the growth South & Central America brain implants market.
Based on treatment, the South & Central America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held 37.5% share of the South & Central America brain implants market in 2022, amassing US$ 137.30 million. It is projected to garner US$ 187.92 million by 2030 to expand at 4.0% CAGR during 2022-2030. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.
Based on application, the South & Central America brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held 38.5% share of the South & Central America brain implants market in 2022, amassing US$ 140.76 million. It is projected to garner US$ 269.23 million by 2030 to expand at 8.4% CAGR during 2022-2030.
Based on end user, the South & Central America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held 72.0% share of the South & Central America brain implants market in 2022, amassing US$ 263.66 million. It is projected to garner US$ 559.41 million by 2030 to expand at 9.9% CAGR during 2022-2030
Based on country, the South & Central America brain implants market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 58.7% share of South & Central America brain implants market in 2022, amassing US$ 214.84 million. It is projected to garner US$ 441.65 million by 2030 to expand at 9.4% CAGR during 2022-2030.
Key players operating in the South & Central America brain implants market are Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Renishaw Plc, among others.
In June 2023; Boston Scientific Corp received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America brain implants market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Brain Implants Market Landscape
4.1 Overview
5. South & Central America Brain Implants Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market – South & Central America Market Analysis
6.1 Overview
6.2 South & Central America Brain Implants Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Brain Implants Market – Revenue and Forecast to 2030 – by Treatment.
7.1 Overview
7.2 South & Central America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Brain Implants Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 South & Central America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson’s disease
8.4.1 Overview
8.4.2 Parkinson’s disease: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s disease
8.5.1 Overview
8.5.2 Alzheimer’s disease: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Brain Implants Market – Revenue and Forecast to 2030 – by End-User
9.1 Overview
9.2 South & Central America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Brain Implants Market – Country Analysis
10.1 South & Central America Brain Implants Market, by Key Country-Revenue, 2022(US $ Million)
10.1.1 South & Central America Brain Implants Market, by Country
10.1.1.1 Brazil
10.1.1.1.1 Brazil: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 Brazil: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.2.1 Brazil: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Brazil: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Argentina
10.1.1.2.1 Argentina: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Argentina: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 Argentina: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Argentina: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 Rest of South & Central America
10.1.1.3.1 Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Rest of South & Central America: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 Rest of South & Central America: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 Rest of South & Central America: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. South & Central America Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in South & Central America Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Renishaw Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Brain Implants Market Segmentation
Table 2. Brazil: South & Central America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: South & Central America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Argentina: South & Central America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina: South & Central America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: South & Central America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Rest of South & Central America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Rest of South & Central America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of South & Central America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Organic Growth Strategies in South & Central America Brain Implants Market
Table 15. Recent Inorganic Growth Strategies in the South & Central America Brain Implants Market
Table 16. Glossary of Terms, South & Central America Brain Implants Market
LIST OF FIGURES
Figure 1. South & Central America Brain Implants Market Segmentation, By Country
Figure 2. South & Central America Brain Implants Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Brain Implants Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 6. Deep Brain Stimulation: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Spinal Cord Stimulation: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Vagus Nerve Stimulator: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Invasive and Non-Invasive Brain-Computer Interfaces: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Responsive Neurostimulation for Seizures: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Auditory Brainstem Implant: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Retrocochlear Hearing Impairment: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cochlear Hearing Impairment: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ophthalmic Aids/Implant: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Chronic Pain: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson’s disease: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Alzheimer’s disease: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Essential Tremor: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Depression: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Dystonia: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Amyotrophic Lateral Sclerosis (ALS): South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Neurofibromatosis 2: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 26. Hospitals: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Specialized Clinics / Neurological Centers: South & Central America Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. South & Central America Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 29. South & Central America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Brazil: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Argentina: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Growth Strategies in South & Central America Brain Implants Market
The List of Companies – South & Central America Brain Implants Market
1. Abbott Laboratories
2. Boston Scientific Corp
3. Medtronic Plc
4. Renishaw Plc
You must be logged in to post a review.
Reviews
There are no reviews yet.